Last year a South African woman took a multibillion-dollar United States pharmaceutical company to court with the aim of securing access to life-changing cystic fibrosis medicines. That case has now been dropped following a reduction in the price charged for the medicines in South Africa. Catherine Tomlinson reports.
The post Fight not yet over as case against Vertex is dropped after cystic fibrosis medicine price cut appeared first on Spotlight.
